Kevin A. Lobo has been CEO of Stryker since 1 October 2012, and also assumed the role of Chairman of the Board on 22 July 2014. Mr Lobo joined Stryker in 2011 and had previously been Group President of Orthopaedics.
Mr Lobo is the chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors and serves on the Board of Directors for Parker Hannifin Corporation, the global leader in motion and control technologies. He is also a member of the Business Roundtable and Business Council and serves on some community boards.
Mr Lobo has a broad business career that includes executive positions in general management and finance. After holding finance positions with KPMG, Unilever and Kraft Canada he spent eight years with Rhone-Poulenc, including roles based in Europeas Corporate Controller of Rhodia, the chemical spin-out and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including President J&J Medical Canada and President of Ethicon Endo Surgery.